• vcard
  • Education
    • J.D., cum laude, Georgetown University Law Center, 2002
    • M.S., Johns Hopkins University, 1998, Engineering and Applied Physics in Biomedicine
    • B.S., University of Kansas, 1995, Chemical Engineering
  • Bar Jurisdictions
    • Admitted to practice before the United States Patent and Trademark Office, 2000
    • Colorado, 2004
    • District of Columbia, 2002

Milan Vinnola leverages her prior hands-on, industrial experience with the FDA and her understanding of biotechnology and pharmaceutical technologies to offer clients real world perspective and guidance in her intellectual property practice. 

Milan’s practice involves:

  • Intellectual property counseling
  • Patent procurement 
  • Technology Transactions, Licensing, and Commercial Contracts and Transactions
  • Involvement in opinion, litigation, interference, and opposition practice

She brings her experience and insight to provide regulatory and compliance advice to US and multinational pharmaceutical, biotechnology, and medical device companies. Milan has advised clients regarding:

  • FDA approval processes
  • Hatch-Waxman issues
  • Good manufacturing practices (GMP)
  • Labeling issues
  • Product promotion issues

She also works closely with clients to identify, monitor and assess the infringement risks of third-party patents, and to evaluate patent enforcement strategy. 

In the transactional area, Milan works closely with corporate and licensing attorneys in technology transactions, license drafting, commercial contracts and transactions, manufacturing and supply chain contracts, and IP diligence matters. Milan's IP diligence work includes assessment of the strength and weakness of client and third party patent portfolios, evaluation of freedom to operate issues and strategic recommendations for maximizing value of developing patent portfolios.  Clients also benefit from insights Milan gained from previous experience as a United States Patent Examiner.

  • Negotiated and closed $10mil cross-border equity investment and exclusive distribution agreement with large Chinese pharmaceutical company on behalf of US based pharmaceutical and medical device company.
  • Assisted ophthalmic medical device company with initial public offering and subsequent public offering of common stock, including issuance of Special Patent Counsel Opinion and Negative Assurance Letter related to company intellectual property.
  • Successfully represented a plaintiff medical device company in a patent infringement action involving mammography technology.
  • Represented a foreign plaintiff in a patent infringement action involving semiconductor light emitting devices.
  • The Arnold Partnership v. Dudas, assisted as Counsel for amici curiae addressing applicability of U.S. Patent and Trademark Office patent term extension rules.
text icon Publications & Presentations
Milan M. Vinnola and Rhiannon I. D’Agostin to Speak at ACI 9th Annual Summit on Biosimilars in New York, New York
June 25-27, 2018
text icon Publications & Presentations
Drafting Patents for Litigation and Licensing
BNA Publishing
Biotechnology Patients, Chapter 9; Bradley C. Wright, Ed.
December 2008; 2009-2012 Supplements; 2 Ed. 2013